The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Alavijeh, Mohammad Sadeghi, Professor
    Co Founder And Managing Direct born in December 1961
    Individual (5 offsprings)
    Officer
    2002-05-17 ~ now
    OF - Director → CIF 0
    Alavijeh, Mohammad Sadeghi, Professor
    Individual (5 offsprings)
    Officer
    2002-05-17 ~ now
    OF - Secretary → CIF 0
  • 2
    Poormand, Ghassem, Dr
    Company Director born in October 1950
    Individual (4 offsprings)
    Officer
    2008-03-26 ~ now
    OF - Director → CIF 0
  • 3
    PHARMIDEX HOLDINGS LIMITED - now
    SHELLCO 128 LIMITED - 2011-12-16
    167-169, Great Portland Street, Fifth Floor, London, United Kingdom
    Active Corporate (2 parents, 2 offsprings)
    Net Assets/Liabilities (Company account)
    503,161 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
  • 4
    A2E PARTNERS LIMITED - 2000-10-10
    57, Princess Street, Manchester, United Kingdom
    Active Corporate (3 parents, 37 offsprings)
    Equity (Company account)
    2 GBP2023-12-31
    Officer
    2011-03-11 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Amiri, Said Amin
    Financier born in September 1956
    Individual (67 offsprings)
    Officer
    2009-07-07 ~ 2011-03-11
    OF - Director → CIF 0
  • 2
    Palmer, Alan Michael, Prof
    Co Founder And Chairman born in January 1958
    Individual (6 offsprings)
    Officer
    2002-05-17 ~ 2008-06-17
    OF - Director → CIF 0
  • 3
    INTERLINK TRADE LIMITED - now
    Mellier House, 26a Albemarle Street, London
    Dissolved Corporate (1 parent, 2 offsprings)
    Equity (Company account)
    1 GBP2022-12-31
    Officer
    2002-05-17 ~ 2002-05-17
    PE - Nominee Director → CIF 0
  • 4
    Mellier House, 26a Albemarle Street, London
    Active Corporate (1 parent, 207 offsprings)
    Equity (Company account)
    1 GBP2023-12-31
    Officer
    2002-05-17 ~ 2002-05-17
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

PHARMIDEX PHARMACEUTICAL SERVICES LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
579,464 GBP2023-06-30
544,982 GBP2022-12-31
Property, Plant & Equipment
1,098,702 GBP2023-06-30
1,063,051 GBP2022-12-31
Fixed Assets
1,678,166 GBP2023-06-30
1,608,033 GBP2022-12-31
Total Inventories
840,272 GBP2023-06-30
661,753 GBP2022-12-31
Debtors
521,106 GBP2023-06-30
713,081 GBP2022-12-31
Cash at bank and in hand
123,613 GBP2023-06-30
88,281 GBP2022-12-31
Current Assets
1,484,991 GBP2023-06-30
1,463,115 GBP2022-12-31
Creditors
-1,450,936 GBP2023-06-30
-1,243,323 GBP2022-12-31
Net Current Assets/Liabilities
34,055 GBP2023-06-30
219,792 GBP2022-12-31
Total Assets Less Current Liabilities
1,712,221 GBP2023-06-30
1,827,825 GBP2022-12-31
Net Assets/Liabilities
917,242 GBP2023-06-30
888,263 GBP2022-12-31
Equity
Called up share capital
136,299 GBP2023-06-30
136,299 GBP2022-12-31
Share premium
1,883,297 GBP2023-06-30
1,841,697 GBP2022-12-31
Retained earnings (accumulated losses)
-1,102,354 GBP2023-06-30
-1,089,733 GBP2022-12-31
Average Number of Employees
382023-01-01 ~ 2023-06-30
382022-07-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Net goodwill
14,597 GBP2023-06-30
14,597 GBP2022-12-31
Development expenditure
665,565 GBP2023-06-30
600,707 GBP2022-12-31
Intangible Assets - Gross Cost
680,162 GBP2023-06-30
615,304 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
14,355 GBP2023-06-30
12,895 GBP2022-12-31
Development expenditure
86,343 GBP2023-06-30
57,427 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
100,698 GBP2023-06-30
70,322 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
1,460 GBP2023-01-01 ~ 2023-06-30
Development expenditure
28,916 GBP2023-01-01 ~ 2023-06-30
Intangible Assets - Increase From Amortisation Charge for Year
30,376 GBP2023-01-01 ~ 2023-06-30
Intangible Assets
Net goodwill
242 GBP2023-06-30
1,702 GBP2022-12-31
Development expenditure
579,222 GBP2023-06-30
543,280 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
47,992 GBP2023-06-30
47,992 GBP2022-12-31
Plant and equipment
2,089,973 GBP2023-06-30
2,143,099 GBP2022-12-31
Furniture and fittings
196,436 GBP2023-06-30
191,910 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
2,334,401 GBP2023-06-30
2,383,001 GBP2022-12-31
Property, Plant & Equipment - Disposals
Plant and equipment
-180,767 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment - Disposals
-180,767 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
4,799 GBP2023-06-30
2,400 GBP2022-12-31
Plant and equipment
1,083,716 GBP2023-06-30
1,177,178 GBP2022-12-31
Furniture and fittings
147,184 GBP2023-06-30
140,372 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,235,699 GBP2023-06-30
1,319,950 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Under hire purchased contracts or finance leases
2,399 GBP2023-01-01 ~ 2023-06-30
Plant and equipment
70,551 GBP2023-01-01 ~ 2023-06-30
Furniture and fittings
6,812 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
79,762 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
-164,013 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-164,013 GBP2023-01-01 ~ 2023-06-30
Property, Plant & Equipment
Land and buildings, Under hire purchased contracts or finance leases
43,193 GBP2023-06-30
45,592 GBP2022-12-31
Plant and equipment
1,006,257 GBP2023-06-30
965,921 GBP2022-12-31
Furniture and fittings
49,252 GBP2023-06-30
51,538 GBP2022-12-31
Raw Materials
124,208 GBP2023-06-30
95,720 GBP2022-12-31
Value of work in progress
716,064 GBP2023-06-30
566,033 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
266,498 GBP2023-06-30
377,613 GBP2022-12-31
Prepayments/Accrued Income
Current
103,545 GBP2023-06-30
128,089 GBP2022-12-31
Other Debtors
Current
28,476 GBP2023-06-30
16,417 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
122,587 GBP2023-06-30
190,962 GBP2022-12-31
Finance Lease Liabilities - Total Present Value
Current
205,122 GBP2023-06-30
195,503 GBP2022-12-31
Trade Creditors/Trade Payables
Current
493,571 GBP2023-06-30
337,896 GBP2022-12-31
Bank Borrowings/Overdrafts
Current
10,029 GBP2023-06-30
10,028 GBP2022-12-31
Other Taxation & Social Security Payable
Current
66,725 GBP2023-06-30
60,166 GBP2022-12-31
Other Creditors
Current
141,916 GBP2023-06-30
157,620 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
267,815 GBP2023-06-30
180,958 GBP2022-12-31
Creditors
Current
1,450,936 GBP2023-06-30
1,243,323 GBP2022-12-31
Finance Lease Liabilities - Total Present Value
Non-current
472,208 GBP2023-06-30
498,125 GBP2022-12-31
Bank Borrowings/Overdrafts
Non-current
24,167 GBP2023-06-30
29,167 GBP2022-12-31
Minimum gross finance lease payments owing
Amounts falling due within one year
205,122 GBP2023-06-30
195,503 GBP2022-12-31
Between one and five year
472,208 GBP2023-06-30
498,125 GBP2022-12-31
Minimum gross finance lease payments owing
677,330 GBP2023-06-30
693,628 GBP2022-12-31
Finance Lease Liabilities - Total Present Value
677,330 GBP2023-06-30
693,628 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
19,611 shares2023-06-30
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2023-01-01 ~ 2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
487,912 GBP2023-06-30
480,768 GBP2022-12-31
Between one and five year
1,918,512 GBP2023-06-30
1,918,512 GBP2022-12-31
More than five year
1,895,863 GBP2023-06-30
2,135,677 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
4,302,287 GBP2023-06-30
4,534,957 GBP2022-12-31
  • PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
    Info
    Registered number 04441512
    167-169 Great Portland Street, Fifth Floor, London W1W 5PF
    Private Limited Company incorporated on 2002-05-17 (23 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-05-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.